Omeros Corporation (OMER)

NGM – Real vaqt narxi. Valyuta: USD

13.71

+0.11 (0.81%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

15.61

+1.90 (13.86%)

Bozordan keyin: Aug 12, 2026, 4:18 PM EDT

10.08.2026

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the second quarter of 2026 on Wednesday, August 12, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company's financial results. Conference Call Details and Webcast Link Instructions To access the live webcast, please.

03.08.2026

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the Centers for Medicare & Medicaid Services (CMS) has granted New Technology Add-On Payment (NTAP) status for YARTEMLEA® (narsoplimab-wuug) under the Fiscal Year (FY) 2027 Hospital Inpatient Prospective Payment System (IPPS) Final Rule. Beginning October 1, 2026, eligible hospitals treating Medicare patients with YARTEMLEA for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) wi.

Videolar

No Data

There is no data to display

Press-relizlar

03.08.2026

Omeros Corporation (OMER)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Omeros Corporation (OMER)

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Videolar

No Data

Press-relizlar

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Videolar

No Data

Press-relizlar

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Search stocks

Omeros Corporation (OMER)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Omeros Corporation (OMER)

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Videolar

No Data

Press-relizlar

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®

Videolar

No Data

Press-relizlar

CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®